Cargando…

Evaluation of MMR Status and PD-L1 Expression Using Specimens Obtained by EUS-FNB in Patients with Pancreatic Ductal Adenocarcinoma (PDAC)

Deficient DNA mismatch repair status (dMMR)/high microsatellite instability have been shown to be predictive biomarkers for immune checkpoint inhibitor drugs which block the programmed death protein-1/programmed death ligand-1 (PD-1/PD-L1) interaction between tumor cells and activated T cells. The a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Constantin, Alina, Iovănescu, Vlad, Cazacu, Irina Mihaela, Ungureanu, Bogdan Silviu, Copăescu, Cătălin, Stroescu, Cezar, Bejinariu, Nona, Săftoiu, Adrian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871161/ https://www.ncbi.nlm.nih.gov/pubmed/35204385 http://dx.doi.org/10.3390/diagnostics12020294

Ejemplares similares

Prognostic biomarkers related to tumoral microenvironment in pancreatic ductal adenocarcinoma: a systematic review
por: Constantin, Alina Liliana, et al.
Publicado: (2021)

Technical Performance, Overall Accuracy and Complications of EUS-Guided Interventional Procedures: A Dynamic Landscape
por: Cherciu Harbiyeli, Irina Florina, et al.
Publicado: (2022)

Gastric Cancer Angiogenesis Assessment by Dynamic Contrast Harmonic Imaging Endoscopic Ultrasound (CHI-EUS) and Immunohistochemical Analysis—A Feasibility Study
por: Sacerdoțianu, Victor Mihai, et al.
Publicado: (2022)

Cardiac sarcoma diagnosed with EUS-FNB
por: Haja, Azimudin, et al.
Publicado: (2021)

Hot topics in therapeutic EUS
por: Tabacelia, Daniela, et al.
Publicado: (2022)

The Role of EUS-Guided FNA and FNB in Autoimmune Pancreatitis
por: de Pretis, Nicolò, et al.
Publicado: (2021)

The best approach for sampling of pancreatic neuroendocrine tumors – EUS-FNA or EUS-FNB?
por: Hedenström, Per
Publicado: (2019)

Current status and issues in genomic analysis using EUS-FNA/FNB specimens in hepatobiliary–pancreatic cancers
por: Ozono, Yoshinori, et al.
Publicado: (2023)

Recent developments in hepatopancreatobiliary EUS
por: Cazacu, Irina M., et al.
Publicado: (2019)

Macroscopic on-site evaluation (MOSE) of specimens from solid lesions acquired during EUS-FNB: multicenter study and comparison between needle gauges
por: Mangiavillano, Benedetto, et al.
Publicado: (2021)

A quarter century of EUS-FNA: Progress, milestones, and future directions
por: Cazacu, Irina Mihaela, et al.
Publicado: (2018)

Endoscopic Ultrasound vs. Computed Tomography for Gastric Cancer Staging: A Network Meta-Analysis
por: Ungureanu, Bogdan Silviu, et al.
Publicado: (2021)

Standardisation of EUS-guided FNB technique for molecular profiling in pancreatic cancer: results of a randomised trial
por: Bang, Ji Young, et al.
Publicado: (2023)

Psychological impact of pancreatic cancer screening by EUS or magnetic resonance imaging in high-risk individuals: A systematic review
por: Cazacu, Irina Mihaela, et al.
Publicado: (2019)

The borderline resectable/locally advanced pancreatic ductal adenocarcinoma: EUS oriented
por: Iordache, Sevastiţa, et al.
Publicado: (2017)

A Morphological and Immunohistochemical Study of the Tumoral and Inflammatory Cells in Pancreatic Ductal Adenocarcinoma
por: Herlea, Vlad, et al.
Publicado: (2020)

Genetic analysis of postoperative recurrence of pancreatic cancer potentially owing to needle tract seeding during EUS-FNB
por: Kawabata, Hidemasa, et al.
Publicado: (2019)

Usefulness of Macroscopic On-Site Evaluation Using a Stereomicroscope during EUS-FNB for Diagnosing Solid Pancreatic Lesions
por: Ishikawa, Takuya, et al.
Publicado: (2022)

Overexpression of Mesothelin in Pancreatic Ductal Adenocarcinoma (PDAC)
por: Le, Kai, et al.
Publicado: (2020)

Diagnostic performance of endoscopic ultrasound-guided tissue acquisition by EUS-FNA versus EUS-FNB for solid pancreatic mass without ROSE: a retrospective study
por: Wong, Thanawin, et al.
Publicado: (2022)

Diagnostic Concordance of Cytology and Histology in Samples Obtained via Endoscopic Ultrasound-Guided Fine-Needle Biopsy (EUS-FNB)
por: Keihanian, Tara, et al.
Publicado: (2021)

Utility of endoscopic ultrasonography-guided fine-needle biopsy (EUS-FNB) for diagnosing small subepithelial lesions (< 20 mm)
por: Sekine, Masanari, et al.
Publicado: (2021)

Validation of a Novel EUS-FNB-Derived Organoid Co-Culture System for Drug Screening in Patients with Pancreatic Cancer
por: Grützmeier, Simon Ezban, et al.
Publicado: (2023)

Tissue amount and diagnostic yield of a novel franseen EUS-FNB and a standard EUS-FNA needle—A randomized controlled study in solid pancreatic lesions
por: Kovacevic, Bojan, et al.
Publicado: (2023)

The role of survivin in the progression of pancreatic ductal adenocarcinoma (PDAC) and a novel survivin-targeted therapeutic for PDAC
por: Brown, Matthew, et al.
Publicado: (2020)

Predicting mortality in patients with nonvariceal upper gastrointestinal bleeding using machine-learning
por: Ungureanu, Bogdan Silviu, et al.
Publicado: (2023)

Modifiable Pancreatic Ductal Adenocarcinoma (PDAC) Risk Factors
por: Michalak, Natalia, et al.
Publicado: (2023)

Efficacy of EUS-guided FNB using a Franseen needle for tissue acquisition and microsatellite instability evaluation in unresectable pancreatic lesions
por: Sugimoto, Mitsuru, et al.
Publicado: (2020)

Endoscopic ultrasound guided fine needle biopsy (EUS-FNB) from peritoneal lesions: a prospective cohort pilot study
por: Kongkam, Pradermchai, et al.
Publicado: (2021)

Outcomes in Patients Admitted for Upper Gastrointestinal Bleeding and COVID-19 Infection: A Study of Two Years of the Pandemic
por: Cazacu, Sergiu Marian, et al.
Publicado: (2023)

SIRT 1 Overexpression is Associated with Metastasis of Pancreatic Ductal Adenocarcinoma (PDAC) and Promotes Migration and Growth of PDAC Cells
por: Li, Siqin, et al.
Publicado: (2016)

Independent risk factors for true malignancy in atypical cytologic diagnostic category in EUS-FNA/FNB of the pancreas: A novel prediction model
por: Zhang, Ping-Ping, et al.
Publicado: (2022)

Morphometric Assessment of Confocal Laser Endomicroscopy for Pancreatic Ductal Adenocarcinoma, an Ex-Vivo Pilot Study
por: Ungureanu, Bogdan Silviu, et al.
Publicado: (2020)

Clinically impactful metabolic subtypes of pancreatic ductal adenocarcinoma (PDAC)
por: Pervin, Jannat, et al.
Publicado: (2023)

EUS-through-the-needle microbiopsy forceps in pancreatic cystic lesions: A systematic review
por: Balaban, Vasile Daniel, et al.
Publicado: (2020)

NLR48 is Better Than CRP, and mCTSI, and Similar to BISAP and SOFA Scores for Mortality Prediction in Acute Pancreatitis: A Comparison of 6 Scores
por: Cazacu, Sergiu Marian, et al.
Publicado: (2023)

Krukenberg Tumor in Association with Ureteral Stenosis Due to Peritoneal Carcinomatosis from Pulmonary Adenocarcinoma: A Case Report
por: Balescu, Irina, et al.
Publicado: (2020)

Mortality Rate in Upper Gastrointestinal Bleeding Associated with Anti-Thrombotic Therapy Before and During Covid-19 Pandemic
por: Popa, Petrica, et al.
Publicado: (2022)

ANO1 (TMEM16A) in pancreatic ductal adenocarcinoma (PDAC)
por: Sauter, D. R. P., et al.
Publicado: (2014)

Systemic therapy in pancreatic ductal adenocarcinomas (PDACs)—basis and current status
por: Ramaswamy, Anant, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i1upofc36561tqi1clc8vcr40v